<DOC>
	<DOCNO>NCT00004396</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare efficacy heme arginate , singly combination tin mesoporphyrin , lower porphyrin precursor patient asymptomatic acute intermittent porphyria . II . Evaluate compare safety tolerability treatment regimens patient population .</brief_summary>
	<brief_title>Studies Porphyria III : Heme Tin Mesoporphyrin Acute Porphyrias</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This unblinded , dose range study . Patients receive heme arginate alone combination tin mesoporphyrin . Patients receive tin mesoporphyrin IV single dose . Heme arginate administer single intravenous infusion . Patients enter cohort 4 . Subsequent cohort 4 patient receive escalate dos tin mesoporphyrin combination 1 2 different dosage heme arginate . Subjects must maintain constant diet . Patients experience adverse reaction follow clinically indicate .</detailed_description>
	<mesh_term>Porphyrias</mesh_term>
	<mesh_term>Porphyria , Erythropoietic</mesh_term>
	<mesh_term>Tin mesoporphyrin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Documented acute intermittent porphyria remission least 1 month Increased excretion porphyrin precursor Absence neurovisceral symptom due porphyria least 1 month Prior/Concurrent Therapy At least 1 month since prior heme preparation therapy Concurrent medication coexist condition allow , long dose pattern administration hold constant study Patient Characteristics Renal : Urinary porphobilinogen excretion least 20 mg every 24 hour Other : Not pregnant Fertile female patient must use effective contraception least 6 month study At least 1 month since symptom disease No concurrent acute hemorrhagic disorder : Gastrointestinal bleed Intracerebral hemorrhage No known hypersensitivity heme arginate , tin mesoporphyrin , another heme preparation , related heme analogue No condition may increase risk patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>inborn error metabolism</keyword>
	<keyword>porphyria</keyword>
	<keyword>rare disease</keyword>
</DOC>